Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Berger, Frédérique"'
Autor:
Lucchi E; Supportive and Palliative Care Department, Institut Curie, Paris, France., Berger F; Biostatistics Department, Institut Curie, Paris, France., Milder M; Biostatistics Department, Institut Curie, Paris, France., Commer JM; Supportive and Palliative Care Department, Institut de Cancerologie de Loire, Anger, France., Morin S; Supportive and Palliative Care Department, Institut Bergonie, Paris, France., Capodano G; Supportive and Palliative Care Department, Institut Paoli-Calmette, Marseille, France., Thomaso M; Supportive and Palliative Care Department, Institut de Cancerologie de Montpellier, Montpellier, France., Fogliarini A; Supportive and Palliative Care Department, Centre Lacassagne, Nice, France., Bremaud N; Supportive and Palliative Care Department, Centre Georges François Leclerc, Dijon, France., Henry A; Supportive and Palliative Care Department, Centre Alexis Vautrin, Nancy, France., Mastroianni B; Supportive and Palliative Care Department, Centre Léon Berard, Lyon, France., Chvetzoff G; Supportive and Palliative Care Department, Centre Léon Berard, Lyon, France., Bouleuc C; Supportive and Palliative Care Department, Institut Curie, Paris, France.
Publikováno v:
The oncologist [Oncologist] 2024 May 03; Vol. 29 (5), pp. e708-e715.
Autor:
Bidard FC; Department of Medical Oncology, Institut Curie, Université Versailles Saint-Quentin, Université Paris-Saclay, Saint-Cloud, France; Circulating Tumour Biomarkers Laboratory, Inserm CIC-BT 1428, Institut Curie, Paris, France. Electronic address: francois-clement.bidard@curie.fr., Hardy-Bessard AC; Department of Medical Oncology, Centre Armoricaind'Oncologie, Plérin, France., Dalenc F; Department of Medical Oncology, Institut Claudius-Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Bachelot T; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Pierga JY; Circulating Tumour Biomarkers Laboratory, Inserm CIC-BT 1428, Institut Curie, Paris, France; Department of Medical Oncology, Institut Curie and Université de Paris, Paris, France., de la Motte Rouge T; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France., Sabatier R; Department of Medical Oncology, Institut Paoli Calmettes, Aix-Marseille Université, Marseille, France., Dubot C; Department of Medical Oncology, Institut Curie, Université Versailles Saint-Quentin, Université Paris-Saclay, Saint-Cloud, France., Frenel JS; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France., Ferrero JM; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France., Ladoire S; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France., Levy C; Department of Medical Oncology, Centre François Baclesse, Caen, France., Mouret-Reynier MA; Department of Medical Oncology, Centre Jean Perrin, Clermont Ferrand, France., Lortholary A; Department of Medical Oncology, Hopital Privé du Confluent, Nantes, France., Grenier J; Department of Medical Oncology, Institut Sainte Catherine, Avignon, France., Chakiba C; Department of Medical Oncology, Institut Bergonié, Bordeaux, France., Stefani L; Department of Medical Oncology, Centre Hospitalier Annecy Genvoi, Pringy-Metz-Tessy, France., Plaza JE; Department of Medical Oncology, UNEOS Site Hôpital Robert Schuman, Vantoux, France., Clatot F; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France., Teixeira L; Department of Medical Oncology, Hôpital Saint Louis, Paris, France., D'Hondt V; Department of Medical Oncology, Institut du Cancer de Montpellier Val d'Aurelle, Montpellier, France., Vegas H; Department of Medical Oncology, Centre Hospitalier de Tours, Hôpital Bretonneau, Tours, France., Derbel O; Department of Medical Oncology, Hôpital Privé Jean Mermoz, Lyon, France., Garnier-Tixidre C; Department of Medical Oncology, Institut Daniel Hollard, G H Mutualiste de Grenoble, Grenoble, France., Canon JL; Department of Medical Oncology, Grand Hôpital de Charleroi, Charleroi, Belgique., Pistilli B; Breast Oncology Department, Gustave Roussy, Villejuif, France., André F; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Arnould L; Department of Pathology, Centre Georges François Leclerc, Dijon, France., Pradines A; INSERM U1037 CNRS ERL5294 UPS, Cancer Research Center of Toulouse, Toulouse, France; Prospective Biology Unit, Medical Laboratory, Claudius Regaud Institute, Toulouse University Cancer Institute, Toulouse, France., Bièche I; Pharmacogenomic Unit, Genetics Laboratory, Department of Diagnostic and Theranostic Medicine, Institut Curie, PSL University, Saint-Cloud, Paris, France., Callens C; Pharmacogenomic Unit, Genetics Laboratory, Department of Diagnostic and Theranostic Medicine, Institut Curie, PSL University, Saint-Cloud, Paris, France., Lemonnier J; Research and Development Department, UNICANCER, Paris, France., Berger F; Biometry Unit, Institut Curie, PSL University, Saint-Cloud, Paris, France., Delaloge S; Breast Oncology Department, Gustave Roussy, Villejuif, France.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2022 Nov; Vol. 23 (11), pp. 1367-1377. Date of Electronic Publication: 2022 Sep 29.
Autor:
Buhagiar-Labarchède G; Institut Curie, PSL Research University, UMR 3348, 91405, Orsay, France.; CNRS UMR 3348, Centre Universitaire, Bat 110, 91405, Orsay, France.; Université Paris-Saclay, Centre Universitaire, Bat 110, UMR 3348, 91405, Orsay, France., Onclercq-Delic R; Institut Curie, PSL Research University, UMR 3348, 91405, Orsay, France.; CNRS UMR 3348, Centre Universitaire, Bat 110, 91405, Orsay, France.; Université Paris-Saclay, Centre Universitaire, Bat 110, UMR 3348, 91405, Orsay, France., Vacher S; Department of Genetics, Institut Curie, Paris, France., Berger F; Department of Biostatistics, Institut Curie, Paris, France., Bièche I; Department of Genetics, Institut Curie, Paris, France.; Université Paris Cité, Paris, France., Stoppa-Lyonnet D; Department of Genetics, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.; INSERM U830, Institut Curie, Paris, France., Amor-Guéret M; Institut Curie, PSL Research University, UMR 3348, 91405, Orsay, France. mounira.amor@curie.fr.; CNRS UMR 3348, Centre Universitaire, Bat 110, 91405, Orsay, France. mounira.amor@curie.fr.; Université Paris-Saclay, Centre Universitaire, Bat 110, UMR 3348, 91405, Orsay, France. mounira.amor@curie.fr.
Publikováno v:
Scientific reports [Sci Rep] 2022 Aug 18; Vol. 12 (1), pp. 14062. Date of Electronic Publication: 2022 Aug 18.
Autor:
Berger F; Biometry Unit, Institut Curie, PSL Research University, Paris and Saint-Cloud, France., Marce M; Biometry Unit, Data Center, Institut Régional du Cancer de Montpellier, Montpellier, France., Delaloge S; Breast Oncology Department, Gustave Roussy, Villejuif, France., Hardy-Bessard AC; Dapartment of Medical Oncology, Centre Armoricaind'Oncologie, Plérin, France., Bachelot T; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Bièche I; Pharmacogenomic Unit, Genetics laboratory, Department of Diagnostic and Theranostic Medicine, Institut Curie and PSL University, Paris, France., Pradines A; INSERM U1037 CNRS ERL5294 UPS, Cancer Research Center of Toulouse, Toulouse, France.; Prospective Biology Unit, Medical Laboratory, Claudius Regaud Institute, Toulouse University Cancer Institute (IUCT-O), Toulouse, France., De La Motte Rouge T; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France., Canon JL; Department of Medical Oncology, Grand Hôpital de Charleroi, Charleroi, Belgique., André F; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Arnould L; Department of Pathology, Centre Georges François Leclerc, Dijon, France., Clatot F; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France., Lemonnier J; Research and Development Department, UNICANCER, Paris, France., Marques S; Research and Development Department, UNICANCER, Paris, France., Bidard FC; Department of Medical Oncology, Institut Curie, UVSQ/Paris Saclay University, Saint Cloud, France francois-clement.bidard@curie.fr.; Circulating Tumor Biomarkers laboratory, Inserm CIC-BT 1428, Institut Curie, Paris, France.
Publikováno v:
BMJ open [BMJ Open] 2022 Mar 03; Vol. 12 (3), pp. e055821. Date of Electronic Publication: 2022 Mar 03.
Autor:
Callens C; Genetics Department, Institut Curie, PSL Research University, Paris, France., Driouch K; Genetics Department, Institut Curie, PSL Research University, Paris, France., Boulai A; Genetics Department, Institut Curie, PSL Research University, Paris, France., Tariq Z; Genetics Department, Institut Curie, PSL Research University, Paris, France., Comte A; Department of Medical Oncology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75005, Paris, France., Berger F; Department of Biostatistics, Institut Curie, Saint-Cloud, France., Belin L; Department of Biostatistics, Institut Curie, Saint-Cloud, France., Bièche I; Genetics Department, Institut Curie, PSL Research University, Paris, France., Servois V; Imaging Department, Institut Curie, PSL Research University, Paris, France., Legoix P; Institut Curie Genomics of Excellence (ICGex) Platform, Institut Curie Research Center, PSL Research University, Paris, France., Bernard V; Institut Curie Genomics of Excellence (ICGex) Platform, Institut Curie Research Center, PSL Research University, Paris, France., Baulande S; Institut Curie Genomics of Excellence (ICGex) Platform, Institut Curie Research Center, PSL Research University, Paris, France., Chemlali W; Genetics Department, Institut Curie, PSL Research University, Paris, France., Bidard FC; Department of Medical Oncology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75005, Paris, France., Fourchotte V; Surgery Department, Institut Curie, Paris, France., Salomon AV; Pathology and Tumor Biology Department, Institut Curie, PSL Research University, Paris, France., Brain E; Medical Oncology, Institut Curie, Saint-Cloud, France., Lidereau R; Genetics Department, Institut Curie, PSL Research University, Paris, France., Bachelot T; Centre Léon Bérard, Lyon, France., Saghatchian M; Gustave Roussy Cancer Campus, Villejuif, France., Campone M; Institut de Cancérologie de l'Ouest Nantes, Nantes, France., Giacchetti S; Hôpital Saint Louis, Breast diseases center, Paris, France., Zafrani BS; Pathology and Tumor Biology Department, Institut Curie, PSL Research University, Paris, France., Cottu P; Department of Medical Oncology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75005, Paris, France. paul.cottu@curie.fr.
Publikováno v:
Genome medicine [Genome Med] 2021 Mar 15; Vol. 13 (1), pp. 44. Date of Electronic Publication: 2021 Mar 15.
Autor:
Cabel L; Department of Medical Oncology, Institut Curie, Paris, France.; Department of Medical Oncology, Institut Curie, Saint Cloud, France.; Circulating Tumor Biomarkers Laboratory, SIRIC2 Institut Curie, Paris, France.; UVSQ, Université Paris-Saclay, Saint Cloud, France., Berger F; Department of Biostatistics, Institut Curie, PSL Research University, Saint Cloud, France., Cottu P; Department of Medical Oncology, Institut Curie, Paris, France.; Department of Medical Oncology, Institut Curie, Saint Cloud, France., Loirat D; Department of Medical Oncology, Institut Curie, Paris, France.; Department of Medical Oncology, Institut Curie, Saint Cloud, France., Rampanou A; Circulating Tumor Biomarkers Laboratory, SIRIC2 Institut Curie, Paris, France., Brain E; Department of Medical Oncology, Institut Curie, Paris, France.; Department of Medical Oncology, Institut Curie, Saint Cloud, France., Cyrille S; Department of Biostatistics, Institut Curie, PSL Research University, Saint Cloud, France., Bourgeois H; Department of Medical Oncology, Centre Jean Bernard, Le Mans, France., Kiavue N; Department of Medical Oncology, Institut Curie, Paris, France.; Department of Medical Oncology, Institut Curie, Saint Cloud, France., Deluche E; Department of Medical Oncology, CHU de Limoges, Limoges, France., Ladoire S; Department of Medical Oncology, CLCC Georges François Leclerc, Dijon, France., Campone M; Department of Medical Oncology, Institut de cancérologie de l'Ouest, Saint-Herblain, France., Pierga JY; Department of Medical Oncology, Institut Curie, Paris, France.; Department of Medical Oncology, Institut Curie, Saint Cloud, France.; Circulating Tumor Biomarkers Laboratory, SIRIC2 Institut Curie, Paris, France.; Université de Paris, Paris, France., Bidard FC; Department of Medical Oncology, Institut Curie, Paris, France. fcbidard@curie.fr.; Department of Medical Oncology, Institut Curie, Saint Cloud, France. fcbidard@curie.fr.; Circulating Tumor Biomarkers Laboratory, SIRIC2 Institut Curie, Paris, France. fcbidard@curie.fr.; UVSQ, Université Paris-Saclay, Saint Cloud, France. fcbidard@curie.fr.
Publikováno v:
British journal of cancer [Br J Cancer] 2021 Mar; Vol. 124 (7), pp. 1207-1213. Date of Electronic Publication: 2021 Jan 21.
Autor:
Bidard FC; Department of Medical Oncology, Institut Curie, UVSQ and Paris-Saclay University, Saint-Cloud, France.; INSERM Center of Clinical Investigations in Biotherapies of Cancer (CIC-BT) 1428, Paris, France., Jacot W; Department of Medical Oncology, Institut du Cancer de Montpellier (ICM), Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Montpellier University, Montpellier, France., Kiavue N; Department of Medical Oncology, Institut Curie, UVSQ and Paris-Saclay University, Saint-Cloud, France., Dureau S; Biometry Unit, Institut Curie, PSL Research University, Paris, France., Kadi A; Biometry Unit, Institut Curie, PSL Research University, Paris, France., Brain E; Department of Medical Oncology, Institut Curie, UVSQ and Paris-Saclay University, Saint-Cloud, France., Bachelot T; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Bourgeois H; Department of Medical Oncology, Victor Hugo Clinic, Le Mans, France., Gonçalves A; Department of Medical Oncology, Institut Paoli-Calmettes, CRCM, Aix-Marseille University, Marseille, France., Ladoire S; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France., Naman H; Department of Medical Oncology, Centre Azuréen de Cancérologie, Mougins, France., Dalenc F; Department of Medical Oncology, Institut Claudius Regaud, Toulouse, France., Gligorov J; Department of Medical Oncology, Hôpital Tenon, Sorbonne Université, Paris, France., Espié M; Department of Medical Oncology, Hôpital Saint-Louis, Paris, France., Emile G; Department of Medical Oncology, Centre François Baclesse, Caen, France., Ferrero JM; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France., Loirat D; Department of Medical Oncology, Institut Curie, Université de Paris, Paris, France., Frank S; Department of Medical Oncology, Institut Curie, Université de Paris, Paris, France., Cabel L; Department of Medical Oncology, Institut Curie, UVSQ and Paris-Saclay University, Saint-Cloud, France., Diéras V; Formerly with Department of Medical Oncology, Institut Curie, Paris, France.; Now with Department of Medical Oncology, Centre Eugène Marquis, Rennes, France., Cayrefourcq L; Laboratory of Rare Human Circulating Cells, University Medical Center of Montpellier, EA 2415, Montpellier University, Montpellier, France., Simondi C; Clinical Research Department, Institut Curie, PSL Research University, Paris, France., Berger F; Biometry Unit, Institut Curie, PSL Research University, Paris, France., Alix-Panabières C; Laboratory of Rare Human Circulating Cells, University Medical Center of Montpellier, EA 2415, Montpellier University, Montpellier, France., Pierga JY; Department of Medical Oncology, Institut Curie, Université de Paris, Paris, France.
Publikováno v:
JAMA oncology [JAMA Oncol] 2021 Jan 01; Vol. 7 (1), pp. 34-41.
Autor:
Boulle G; Department of Radiation Oncology, Institut Curie, Paris-St Cloud, France., Saint-Martin C; Department of Biostatistics, Institut Curie, Paris-St Cloud, France., De La Lande B; Department of Radiation Oncology, Institut Curie, Paris-St Cloud, France., Laki F; Department of Surgical Oncology, Institut Curie, Paris, France., Bidoz NF; Department of Radiation Oncology, Institut Curie, Paris-St Cloud, France., Berger F; Department of Biostatistics, Institut Curie, Paris-St Cloud, France., Veret A; Department of Radiation Oncology, Institut Curie, Paris-St Cloud, France., Bragard C; Department of Biostatistics, Institut Curie, Paris-St Cloud, France., Fourquet A; Department of Radiation Oncology, Institut Curie, Paris-St Cloud, France., Kirova YM; Department of Radiation Oncology, Institut Curie, Paris-St Cloud, France. Electronic address: youlia.kirova@curie.fr.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2019 Jul 15; Vol. 104 (4), pp. 877-884. Date of Electronic Publication: 2019 Mar 27.
Autor:
Mignot F; Department of Radiation Oncology, Institut Curie, PSL Research University, Paris, France., Loirat D; Department of Medical Oncology, Institut Curie, PSL Research University, Paris and Saint Cloud, France., Dureau S; Department of Biostatistics, Institut Curie, PSL Research University, Saint Cloud, France., Bataillon G; Department of Pathology, Institut Curie, PSL Research University, Paris, France., Caly M; Department of Pathology, Institut Curie, PSL Research University, Paris, France., Vincent-Salomon A; Department of Pathology, Institut Curie, PSL Research University, Paris, France., Berger F; Department of Biostatistics, Institut Curie, PSL Research University, Saint Cloud, France., Fourquet A; Department of Radiation Oncology, Institut Curie, PSL Research University, Paris, France., Pierga JY; Department of Medical Oncology, Institut Curie, PSL Research University, Paris and Saint Cloud, France; Circulating Tumor Biomarkers Laboratory, Siric, Institut Curie, PSL Research University, Paris, France; Université Paris Descartes, Paris, France., Kirova YM; Department of Radiation Oncology, Institut Curie, PSL Research University, Paris, France. Electronic address: youlia.kirova@curie.fr., Bidard FC; Department of Medical Oncology, Institut Curie, PSL Research University, Paris and Saint Cloud, France; Circulating Tumor Biomarkers Laboratory, Siric, Institut Curie, PSL Research University, Paris, France; UVSQ, Paris Saclay University, Paris, France.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2019 Feb 01; Vol. 103 (2), pp. 389-396. Date of Electronic Publication: 2018 Oct 04.
Autor:
Bronsart E; Institut Curie, Department of Radiation Oncology, Paris, France., Dureau S; Institut Curie, Unit of Biometry, Paris, France., Xu HP; Institut Curie, Department of Radiation Oncology, Paris, France; Department of Radiation Oncology, Ruijin Hospital, Shanghai, China., Bazire L; Institut Curie, Department of Radiation Oncology, Paris, France., Chilles A; Institut Curie, Department of Radiation Oncology, Paris, France., Costa E; Institut Curie, Department of Radiation Oncology, Paris, France., Logerot C; Institut Curie, Department of Radiation Oncology, Paris, France., Falcou MC; Institut Curie, Department of Public Health, Paris, France., Campana F; Institut Curie, Department of Radiation Oncology, Paris, France., Berger F; Institut Curie, Unit of Biometry, Paris, France., Fourquet A; Institut Curie, Department of Radiation Oncology, Paris, France., Kirova YM; Institut Curie, Department of Radiation Oncology, Paris, France. Electronic address: youlia.kirova@curie.fr.
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2017 Aug; Vol. 124 (2), pp. 214-219. Date of Electronic Publication: 2017 Jul 19.